What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Breast cancer
Andrew R. Green mainly investigates Breast cancer, Cancer, Pathology, Internal medicine and Oncology.
The various areas that Andrew R. Green examines in his Breast cancer study include Immunohistochemistry, Tissue microarray, Cancer research and Carcinoma.
His work carried out in the field of Cancer brings together such families of science as Clinical trial and Genome.
Andrew R. Green interconnects Basal, Angiogenesis and Lymphovascular invasion in the investigation of issues within Pathology.
His work in Internal medicine addresses subjects such as Endocrinology, which are connected to disciplines such as Antiestrogen, Fulvestrant and Transferrin receptor.
He has included themes like Lymph node, Clinical significance, Breast carcinoma, Proportional hazards model and Hazard ratio in his Oncology study.
His most cited work include:
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (3323 citations)
- Prognostic markers in triple‐negative breast cancer (979 citations)
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer (872 citations)
What are the main themes of his work throughout his whole career to date?
Andrew R. Green spends much of his time researching Breast cancer, Internal medicine, Oncology, Cancer research and Pathology.
His studies deal with areas such as Immunohistochemistry and Tissue microarray as well as Breast cancer.
The concepts of his Immunohistochemistry study are interwoven with issues in Lymphovascular invasion and Gene expression.
His Oncology study incorporates themes from Basal, Stage, Lymph node, Biomarker and Survival analysis.
The study incorporates disciplines such as Cancer cell, Carcinogenesis, Immunology, Receptor and DNA repair in addition to Cancer research.
His biological study spans a wide range of topics, including Ductal carcinoma and Chemotherapy.
He most often published in these fields:
- Breast cancer (70.89%)
- Internal medicine (38.67%)
- Oncology (35.76%)
What were the highlights of his more recent work (between 2017-2021)?
- Breast cancer (70.89%)
- Internal medicine (38.67%)
- Oncology (35.76%)
In recent papers he was focusing on the following fields of study:
Andrew R. Green mostly deals with Breast cancer, Internal medicine, Oncology, Cancer research and Immunohistochemistry.
His Breast cancer research is multidisciplinary, incorporating elements of Tissue microarray and Cohort.
His studies examine the connections between Oncology and genetics, as well as such issues in Estrogen receptor, with regards to Neratinib and Lobular Breast Carcinoma.
His study on Cancer research also encompasses disciplines like
- Cancer cell which connect with Gene knockdown,
- Metastasis which connect with Carcinogenesis.
His Immunohistochemistry research incorporates themes from Biomarker and Receptor.
His research integrates issues of Carcinoma, Malignancy and Pathology in his study of Ductal carcinoma.
Between 2017 and 2021, his most popular works were:
- Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. (77 citations)
- The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours (47 citations)
- Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival. (40 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Breast cancer
His primary areas of study are Breast cancer, Cancer research, Cancer, Immunohistochemistry and Internal medicine.
Specifically, his work in Breast cancer is concerned with the study of Ductal carcinoma.
His work deals with themes such as Cell growth, Receptor, Messenger RNA, Disease and Glutaminolysis, which intersect with Cancer research.
Andrew R. Green has researched Cancer in several fields, including Enhancer and Glutaminase.
His research in Immunohistochemistry intersects with topics in Biomarker, Hormonal therapy, Endocrine system and Ku70.
His Internal medicine study frequently links to other fields, such as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
